Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG
Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG
Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
126 <strong>Annual</strong> Financial Statement Konzern-Jahresabschluss<br />
4. Notes to the consolidated balance sheet<br />
4.1. Intangible assets<br />
The goodwill results mainly from the first consolidation, no systematic amortization will be done.<br />
The concessions and intellectual property rights result mainly from acquisitions related to the photodynamic<br />
therapy (“PDT”) and the drug Foscan®.<br />
Intangible assets Goodwill<br />
Acquisition costs<br />
K Euro<br />
Concessions,<br />
IP rights and<br />
licenses<br />
K Euro<br />
Payments<br />
on account<br />
K Euro<br />
Total<br />
K Euro<br />
July 1, <strong>2009</strong> 4,700 4,781 1,236 10,717<br />
Additions 42 170 967 1,179<br />
Currency differences 0 94 0 94<br />
Reclassifications 950 (950) 0 0<br />
Disposals (950) (600) 0 (1,550)<br />
June 30, <strong>2010</strong> 4,742 3,495 2,203 10,440<br />
Cumulative depreciation<br />
July 1, <strong>2009</strong> 374 360 0 734<br />
Additions 358 433 0 791<br />
Reclassifications 0 0 0 0<br />
Disposals 0 0 0 0<br />
June 30, <strong>2010</strong> 732 793 0 1,525<br />
Residual book values<br />
June 30, <strong>2010</strong> 4,010 2,702 2,203 8,915<br />
July 1, <strong>2009</strong> 4,326 4,421 1,236 9,983
Change language